Life Sciences & Medicine Active Updated Jul 23, 2026

A cochlear implant for vision

Science Corporation's retinal implant restores enough central vision for people who lost it to age-related macular degeneration to read books and recognize road signs again. The arc will run as the device, just cleared for commercial sale in Europe, moves toward a possible US launch and wider real-world use.

The story so far

  1. Jul 23, 2026 Latest

    Science Corporation announced European regulatory approval for commercial sale of its retinal implant, which restores enough central vision for age-related macular degeneration patients to read books and make out road signs again. Founder Max Hodak called it a cochlear implant for vision, and the company expects a US launch as soon as 2027.

    Today Got Better

This story moves with the morning letter.

When this arc advances, the timeline above grows the same morning. One short, warm letter with the day's real progress in science, medicine and beyond. Free, every day.